Shubham Khandve: Cell and Gene Therapy is No Longer the Future
Shubham Khandve, Manager at Spherical Insights LLP, shared on LinkedIn:
”Cell and gene therapy is no longer the future.
Download PDF Brochure.
It’s here – and it’s transforming medicine in real time.
The FDA has now approved dozens of therapies that repair, replace, or reprogram human cells.
Each one represents a shift from treating symptoms to correcting the root cause.
- The largest category is hematologic, covering diseases like lymphoma, multiple myeloma, and hemophilia.
- Oncology is next, led by CAR-T cell therapies like Kymriah, Yescarta, and Breyanzi.
- Neurologic treatments such as Zolgensma and Skysona are rewriting outcomes for genetic disorders once considered untreatable.
- Ophthalmologic and dermatologic approvals, like Luxturna and Vyjuvek, restore vision and skin integrity at the genetic level.
Every name on this chart represents years of research, clinical trials, and the hope of a cure – not just control.
Cell and gene therapy is moving medicine from management to molecular repair.
This is the start of a new era in healthcare.
Cell and gene therapy isn’t coming – it’s here.
The FDA has approved dozens of treatments that repair rather than manage disease.
We’re entering the age of molecular medicine, where the cure is written into your cells.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin